论文部分内容阅读
目的:探讨中西医结合治疗肺癌的临床疗效。方法:将80例肺癌患者随机分为治疗组和对照组,每组40例,对照组给予NP方案化疗,治疗组在化疗基础上予自拟扶正肃肺中药治疗。观察两组患者原发病灶的临床治疗效果、5年内生存率;观察两组患者的毒副反应。结果:治疗组总有效率为75.0%,对照组总有效率为55.0%,两组比较,差异有统计学意义(P<0.05);两组患者5年内生存率比较,治疗组明显优于对照组(P<0.05);治疗组毒副反应明显少于对照组(P<0.05或P<0.01)。结论:中西医结合治疗肺癌有较好疗效及安全性。
Objective: To explore the clinical efficacy of integrated traditional Chinese and western medicine in the treatment of lung cancer. Methods: Eighty patients with lung cancer were randomly divided into treatment group and control group, 40 cases in each group. The control group was given NP chemotherapy. The treatment group was given Fuzheng Su-lung Chinese medicine treatment on the basis of chemotherapy. To observe the clinical treatment effect of primary lesions in two groups of patients, 5-year survival rate; observed two groups of patients with side effects. Results: The total effective rate was 75.0% in the treatment group and 55.0% in the control group, with significant difference between the two groups (P <0.05). The 5-year survival rate of the two groups was significantly better than that of the control group (P <0.05). The side effects of the treatment group were less than those of the control group (P <0.05 or P <0.01). Conclusion: The combination of traditional Chinese and Western medicine treatment of lung cancer has a good effect and safety.